Neuromuscular DiseaseInfo Center
Episodic Cluster Headache Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved an injection to treat episodic cluster headaches in adults.
Cracking Down on Illegal Alzheimer's Treatments
The US Food and Drug Administration (FDA) has taken action against 17 companies that were illegally selling products claiming to treat Alzheimer’s disease.
Two New Ways to Prevent Migraines
The US Food and Drug Administration (FDA) has approved two new medications to prevent migraines in adults.
Paint Exposure and MS: A Possible Link
A recent study found a possible link between organic solvents and increased multiple sclerosis (MS) risk in people with genes that make them more susceptible to developing the condition.
Illegal Online Pharmacies: Are You at Risk?
The US Food and Drug Administration (FDA) is warning consumers about nine online networks that are illegally marketing opioids.
Promoting Alzheimer's Awareness
June is Alzheimer's & Brain Awareness Month. This month, health officials are hoping to raise awareness about Alzheimer's disease and other forms of dementia.
How to Fight a Migraine
June is National Migraine and Headache Awareness Month. That means it's the perfect time to review some tips for alleviating migraine and headache pain.
A New Match for Migraines
The US Food and Drug Administration (FDA) has approved a new medication to prevent migraines.
Are You at Risk of Osteoporosis?
Are you at risk of breaking a bone?
MS Treatment Approved for Children
The US Food and Drug Administration (FDA) has expanded the approval of a multiple sclerosis (MS) medication to treat the condition in children.